h-header

news

News dal mondo

02

Dic

Lonza sells Micro-Macinazione site in Switzerland to CDMO Microsize and Schedio Group

Microsize, a U.S.-based contract development and manufacturing organization (CDMO) specializing in particle size reduction and control technologies, has signed an agreement to acquire from Lonza its Micro-Macinazione (Mic Mac) dedicated micronization facility in Monteggio, Switzerland.

Under the deal for an undisclosed amount, Schedio Group — a Swiss-based provider of jet mills, isolators, spray dryers, and engineering services — is also investing with Microsize to strengthen and localize its operational base in Europe, according to the announcement. Both companies will invest in Mic Mac to boost its capabilities and hasten modernization...[PharmaManufacturing]

24

Feb

Industry clamors for clearer guidance on transition to ICH M4Q(R2)

The pharmaceutical industry has expressed a need for greater clarity regarding the timeline for converting...

23

Feb

USA . La Corte Suprema boccia i dazi globali di Trump: cosa cambia e perché il pharma resta nel mirino

l 20 febbraio 2026 la Supreme Court of the United States ha inferto un duro colpo alla strategia commerciale...

20

Feb

NerPharma acquistata da un colosso farmaceutico francese

N           Nerpharma, l’azienda di produzione farmaceutica del gruppo...

20

Feb

Generic industry against giving fee breaks to firms setting up operations in the US

The generic drug industry told the US Food and Drug Administration (FDA) that it opposes waiving annual...

slider-banner

h-footer